The impact of curcumin pill on quality of life and signs of irritable bowel syndrome in patients referred to Amir Al-Momenin hospital in Arak

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N131

Enrollment

Registered

2020-01-24

Start date

2019-08-23

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: The 500 milligram tablets of turmeric (Institute of Medicinal Plants of Academic Jahad) will be given twice daily after lunch and dinner for four weeks. Interventio

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Irritable bowel syndrome, according to a gastroenterologist Age 20 to 50 years No history of any bowel surgery No catching epilepsy, diabetes, hypertension, kidney and bile stones, hepatitis, heart disease and hyperlipidemia No use of hypoglycemic drugs, hypertensive drugs ,blood thinners, corticosteroids and non-steroidal anti-inflammatory drugs Lack of known sensitivity to turmeric

Exclusion criteria

Exclusion criteria: People are reluctant to continue research for any reason Pregnancy during the study Feeling uncomfortable taking medication

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: At baseline and one month after intervention. Method of measurement: WHO Quality of Life-BREF.;The severity of irritable bowel symptoms. Timepoint: At baseline and one month after intervention. Method of measurement: Physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Azim Forouzan

Arak University of Medical Sciences

forouzan@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026